IGF2 and cancer: The DTX3c behavior in this study was clearly opposed to the cancer-promoting effects linked to IGF-II- /EphB4 overexpression described in the literature [56,57] support a tumor-suppressing role for DTX3 similar to other studies reviewed herein in cancer cellular models.